Skip to content

H2020HORIZONFP7

Mimetas BV

Country
NLNetherlands
Defence projects
0
Projects, all programmes
20
As coordinator
1
EU contribution (CORDIS)
EUR 7,863,587
Active
2013 to 2024

Projects

20 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
SECRETExploring the therapeutic potential of perinatal cell SECRETomesHORIZON2024ParticipantEUR 274,370
GRIPonMASHGRIP on MASH: Global Research Initiative for Patient Screening on MASHHORIZON2023ParticipantEUR 242,736
GLIORESOLVETraining the next-generation of European GLIOblastoma (translational) researchers, to RESOLVE precision targeting of the brain tumour microenvironmentHORIZON2022ParticipantEUR 274,370
OrganoPlate GraftOrgan-on-a-Chip technology for in vitro grafting and vascularisation of 3D tissuesH20202019CoordinatorEUR 2,110,303
ENTRAINENdoThelial macRophage Alliance In NeuroinflammationH20202019ParticipantEUR 265,620
TUBETransport derived Ultrafines and the Brain EffectsH20202019ParticipantEUR 400,393
IM2PACTInvestigating Mechanisms and Models Predictive of Accessibility of Therapeutics (IM2PACT) Into The BrainH20202019ParticipantEUR 251,813
PD-MitoQUANTPD-MitoQUANT – A quantitative approach towards the characterisation of mitochondrial dysfunction in Parkinson's diseaseH20202019ParticipantEUR 249,228
FunHoMicDeciphering the fungus-host-microbiota interplay to improve the management of fungal infectionsH20202019ParticipantEUR 265,620
PRECODEPancREatic Cancer OrganoiDs rEsearch NetworkH20202019ParticipantEUR 265,620
iPLACENTAInnovation in modelling Placenta for Maternal and Fetal HealthH20202018ParticipantEUR 510,749
PoLiMeRPolymers in the Liver: Metabolism and RegulationH20202018ParticipantEUR 265,620
LOGIC LABMolecular logic lab-on-a-vesicle for intracellular diagnosticsH20202018ParticipantEUR 265,620
GLIOTRAINExploiting GLIOblastoma intractability to address European research TRAINing needs in translational brain tumour research, cancer systems medicine and integrative multi-omicsH20202017PartnerEUR 0
MIMICMimicking organs on chips for high throughput drug screening and basic researchH20202016ParticipantEUR 255,374
ADAPTEDAlzheimers Disease Apolipoprotein Pathology for Treatment Elucidation and Development - Sofia ref.: 115975H20202016ParticipantEUR 305,102
BIOPOLBiochemical and mechanochemical mechanisms in polarized cellsH20202015ParticipantEUR 255,374
SysMedPDSystems Medicine of Mitochondrial Parkinson’s DiseaseH20202015ParticipantEUR 596,050
CoSTREAMCommon mechanisms and pathways in Stroke and Alzheimer's disease.H20202015ParticipantEUR 509,625
CAM-PACIntegrative Analysis of Gene Functions in Cellular and Animal Models of Pancreatic CancerFP72013ParticipantEUR 300,000

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.